Tumor-targeted chemotherapy with SMANCS in lipiodol for renal cell carcinoma: longer survival with larger size tumors (Q47243355)

12 January 2018

title

Tumor-targeted chemotherapy with SMANCS in lipiodol for renal cell carcinoma: longer survival with larger size tumors (English)

1 reference

12 January 2018

1 reference

Tsuchiya K

1

1 reference

12 January 2018

Uchida T

2

1 reference

12 January 2018

Kobayashi M

3

1 reference

12 January 2018

Maeda H

4

1 reference

12 January 2018

Konno T

5

1 reference

12 January 2018

Yamanaka H

6

1 reference

12 January 2018

language of work or name

English

0 references

publication date

1 April 2000

1 reference

12 January 2018

published in

Urology

1 reference

12 January 2018

volume

55

1 reference

12 January 2018

issue

4

1 reference

12 January 2018

page(s)

495-500

1 reference

12 January 2018

Interferon therapy for the treatment of renal cancer

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900537-3

7 January 2021

Phase II study of interferon-alpha and chemotherapy (5-fluorouracil and mitomycin C) in metastatic renal cell cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900537-3

7 January 2021

Treatment of Renal Adenocarcinoma by Embolic Occlusion of the Renal Circulation

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900537-3

7 January 2021

Conjugation of poly(styrene-co-maleic acid) derivatives to the antitumor protein neocarzinostatin: pronounced improvements in pharmacological properties

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900537-3

7 January 2021

Selective targeting of anti-cancer drug and simultaneous image enhancement in solid tumors by arterially administered lipid contrast medium

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900537-3

7 January 2021

Effect of arterial administration of high-molecular-weight anticancer agent SMANCS with lipid lymphographic agent on hepatoma: a preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900537-3

7 January 2021

Anticancer effects of arterial administration of the anticancer agent SMANCS with lipiodol on metastatic lymph nodes

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900537-3

7 January 2021

Tumor-targeted chemotherapy with lipid contrast medium and macromolecular anticancer drug (SMANCS) for renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900537-3

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900537-3

7 January 2021

The results of radical nephrectomy for renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900537-3

7 January 2021

Image enhancement in computerized tomography for sensitive diagnosis of liver cancer and semiquantitation of tumor selective drug targeting with oily contrast medium

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900537-3

7 January 2021

Tumor size of renal cell carcinoma: its clinical implication

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900537-3

7 January 2021

A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900537-3

7 January 2021

10.1016/S0090-4295(99)00537-3

Identifiers

DOI

1 reference

12 January 2018

release_7ly53fw4rva57b2oaa5xrkagr4

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/7ly53fw4rva57b2oaa5xrkagr4

24 November 2022

mapped directly with Wikidata item

1 reference

12 January 2018